During treatment delivery, an isotropic dose can be applied directly to the tumor bed, sparing healthy tissue and critical structures. Maximizes dose to the target.
Intrabeam. High dose rate, low energy X-rays. Minimal shielding requirements for personnel in the operating room. No need to hide behind concrete walls or heavy beam-stopping equipment.
Safe for the medical staff, safe for the patient, and safe for the environment.
Carl Zeiss | Medical Technology,System Solutions
Carl Zeiss is a leading international group of companies operating worldwide in the optical and opto-electronic industries. Headquartered in Oberkochen, Germany, the Carl Zeiss Group is directly represented in more than 30 countries and operates production facilities in Europe, America and Asia.
The Carl Zeiss Group is structured as six business groups in three strategic markets. These are Biosciences and Medical Technology, System Solutions for Industry and Optical Consumer Goods. We offer products and services for biomedical research and medical technology, system solutions for the semiconductor, automotive and mechanical engineering industries, as well as high quality consumer goods such as eyeglass lenses, camera lenses and binoculars.
Carl Zeiss commenced operations in Australia with the establishment of a Sydney office in 1961. Following strong growth and customer support, the first direct Carl Zeiss office was established in New Zealand in 1978. Today, the Carl Zeiss Australasia Head Office is located in Sydney, Australia, supported by our Auckland based New Zealand office. Our products are also distributed through several select business partners whose market presence allow us to provide sales and service for a variety of customer segments to any location in Australasia.